1. Home
  2. SIDU vs BCYC Comparison

SIDU vs BCYC Comparison

Compare SIDU & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sidus Space Inc.

SIDU

Sidus Space Inc.

HOLD

Current Price

$2.07

Market Cap

243.4M

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$3.97

Market Cap

291.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIDU
BCYC
Founded
2012
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
243.4M
291.8M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
SIDU
BCYC
Price
$2.07
$3.97
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$13.90
AVG Volume (30 Days)
5.8M
332.7K
Earning Date
05-14-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
66.94
N/A
EPS
N/A
N/A
Revenue
$3,383,878.00
N/A
Revenue This Year
$171.29
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$3.75
52 Week High
$6.79
$9.16

Technical Indicators

Market Signals
Indicator
SIDU
BCYC
Relative Strength Index (RSI) 46.18 43.08
Support Level $2.00 $3.94
Resistance Level $3.12 $4.52
Average True Range (ATR) 0.17 0.15
MACD 0.09 -0.01
Stochastic Oscillator 73.28 33.90

Price Performance

Historical Comparison
SIDU
BCYC

About SIDU Sidus Space Inc.

Sidus Space Inc is a space and defense technology company with core capabilities that include dual use satellite manufacturing & technology integration, AI products and services, space and defense hardware components and space-based data solutions. The company generates revenue through a combination of: Satellite platform sales and customization, Payload hosting and mission services, Engineering and systems integration services, and Space and defense hardware manufacturing. The firm supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers. The firm generates revenue principally from satellite platform and payload hosting contracts, manufacturing and engineering services, mission operations, and sales of proprietary hardware products.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Share on Social Networks: